GALIDESIVIR

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C11H15N5O3
Molecular Weight	265.2685
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of GALIDESIVIR

Structure Search

SMILES

NC1=C2NC=C([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1

InChI

InChIKey=AMFDITJFBUXZQN-KUBHLMPHSA-N

InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C11H15N5O3
Molecular Weight	265.2685
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	4 / 4
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 20:36:45 UTC 2023` Edited by `admin` on `Fri Dec 15 20:36:45 UTC 2023`
Record UNII	OLF97F86A7
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GALIDESIVIR

Official Name

English

3,4-PYRROLIDINEDIOL, 2-(4-AMINO-5H-PYRROLO(3,2-D)PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)-, (2S,3S,4R,5R)-

Systematic Name

English

galidesivir [INN]

Common Name

English

BCX4430

Code

English

Galidesivir [WHO-DD]

Common Name

English

BCX-4430

Code

English

IMMUCILLIN A

Common Name

English

Code System Code Type Description

SMS_ID

300000017472

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

DRUG BANK

DB11676

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

NCI_THESAURUS

C172613

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

WIKIPEDIA

Galidesivir

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

PUBCHEM

10445549

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

CAS

249503-25-1

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

FDA UNII

OLF97F86A7

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

INN

10284

Created by admin on Fri Dec 15 20:36:45 UTC 2023 , Edited by admin on Fri Dec 15 20:36:45 UTC 2023

PRIMARY

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->INHIBITOR

Comments:

Has shown antiviral activities in preclinical studies against many RNA viruses, including SARS and MERS.

Amount:


					O75MG3V0ZZ

2-PYRROLIDINEMETHANOL, 5-(4-AMINO-5H-PYRROLO(3,2-D)PYRIMIDIN-7-YL)-4-HYDROXY-, (2S,4R,5S)-

DERIVATIVE -> PARENT

Amount:


					H9E46H7JYJ

RNA-DEPENDENT RNA POLYMERASE COMPLEX (COVID 2019 VIRUS)

TARGET -> INHIBITOR

Amount:


					3R8G5WNW24

ZAIRE EBOLAVIRUS

TARGET ORGANISM->INHIBITOR

Amount:


					1EL1K52SH1

GALIDESIVIR HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					4G601DAM77

YELLOW FEVER VIRUS

TARGET ORGANISM->INHIBITOR

Amount:


					8O959JJ0F0

2-PYRROLIDINEMETHANOL, 5-(4-AMINO-5H-PYRROLO(3,2-D)PYRIMIDIN-7-YL)-3-HYDROXY-4-METHOXY-, (2R,3R,4S,5S)-

DERIVATIVE -> PARENT

Amount:


					ZS35O9OIY0

MERS-COV

TARGET ORGANISM->INHIBITOR

Amount:


					V3TT17X10Q

GALIDESIVIR DIHYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					F0PB9L1GB1

2-PYRROLIDINEMETHANOL, 5-(4-AMINO-5H-PYRROLO(3,2-D)PYRIMIDIN-7-YL)-3-HYDROXY-, (2R,3S,5R)-

ANALOGUE->PARENT

Amount:

Related Record Type Details


					OLF97F86A7

ACTIVE MOIETY

Amount: